Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 4
1989 4
1990 1
1991 4
1992 14
1993 17
1994 35
1995 28
1996 32
1997 32
1998 43
1999 40
2000 38
2001 35
2002 27
2003 37
2004 34
2005 52
2006 34
2007 40
2008 25
2009 20
2010 21
2011 29
2012 17
2013 20
2014 14
2015 11
2016 12
2017 3
2018 11
2019 13
2020 8
2021 11
2022 1
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

741 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean odri (106 results)?
Trandolapril.
[No authors listed] [No authors listed] 2019 Feb 28. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2019 Feb 28. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000181 Free Books & Documents. Review.
Because no information is available on the use of trandolapril during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant....
Because no information is available on the use of trandolapril during breastfeeding, an alternate drug may be preferred, especially w …
Using ACE inhibitors appropriately.
Bicket DP. Bicket DP. Am Fam Physician. 2002 Aug 1;66(3):461-8. Am Fam Physician. 2002. PMID: 12182524 Free article. Review.
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Helal F, Lane ME. Helal F, et al. Eur J Pharm Biopharm. 2014 Sep;88(1):1-7. doi: 10.1016/j.ejpb.2014.03.007. Epub 2014 Mar 20. Eur J Pharm Biopharm. 2014. PMID: 24657822 Review.
Captopril, enalapril maleate, lisinopril dihydrate, perindopril erbumine and trandolapril are the most studied in connection with transdermal preparations. ...
Captopril, enalapril maleate, lisinopril dihydrate, perindopril erbumine and trandolapril are the most studied in connection with tra …
Tarka (trandolapril/verapamil hydrochloride extended-release) overdose.
Cohen V, Jellinek SP, Fancher L, Sangwan G, Wakslak M, Marquart E, Farahani C. Cohen V, et al. J Emerg Med. 2011 Mar;40(3):291-5. doi: 10.1016/j.jemermed.2008.10.015. Epub 2009 Feb 26. J Emerg Med. 2011. PMID: 19249183 Review.
BACKGROUND: Patients with fixed-dose combination product overdoses involving verapamil and trandolapril may present differently than sole calcium channel blocker (CCB) or angiotensin-converting enzyme inhibitor (ACE-I) overdose alone, and may have implications for the toxi …
BACKGROUND: Patients with fixed-dose combination product overdoses involving verapamil and trandolapril may present differently than …
Trandolapril/verapamil combination in hypertensive diabetic patients.
García Donaire JA, Ruilope LM. García Donaire JA, et al. Vasc Health Risk Manag. 2007;3(1):77-82. Vasc Health Risk Manag. 2007. PMID: 17583177 Free PMC article. Review.
Angiotensin-converting enzyme inhibitors and calcium-channel blockers as a combination have theoretically compelling advantages for vessel homeostasis. Trandolapril/verapamil sustained release combination has showed beneficial effects on cardiac and renal systems as well a …
Angiotensin-converting enzyme inhibitors and calcium-channel blockers as a combination have theoretically compelling advantages for vessel h …
Trandolapril: a newer angiotensin-converting enzyme inhibitor.
Guay DR. Guay DR. Clin Ther. 2003 Mar;25(3):713-75. doi: 10.1016/s0149-2918(03)80107-8. Clin Ther. 2003. PMID: 12852701 Review.
The fixed-dose combination of trandolapril and verapamil extended release (ER) is approved for the treatment of hypertension only. ...In the Trandolapril Cardiac Evaluation, trandolapril also significantly reduced all-cause mortality, cardiovascular mortality …
The fixed-dose combination of trandolapril and verapamil extended release (ER) is approved for the treatment of hypertension only. .. …
Combination treatment in hypertension: the VeraTran Study.
Mancia G, Omboni S, Grassi G. Mancia G, et al. Am J Hypertens. 1997 Jul;10(7 Pt 2):153S-158S. doi: 10.1016/s0895-7061(97)00104-0. Am J Hypertens. 1997. PMID: 9231892 Review.
It will also discuss the results of the VeraTran Study, a multicenter study performed according to a double-blind parallel group design and aimed at assessing the antihypertensive efficacy of the fixed combination verapamil slow release (SR) and trandolapril, administered …
It will also discuss the results of the VeraTran Study, a multicenter study performed according to a double-blind parallel group design and …
Trandolapril: a clinical profile.
de Leeuw PW. de Leeuw PW. Am J Hypertens. 1995 Oct;8(10 Pt 2):68S-70S. doi: 10.1016/0895-7061(95)00192-1. Am J Hypertens. 1995. PMID: 8845087 Review.
Trandolapril is a new angiotensin converting enzyme (ACE) inhibitor that effectively lowers blood pressure in doses up to 2 mg. ...Blood pressure is controlled by the drug in about 60% of patients with a side effect profile that is comparable to that of the other ACE inhib …
Trandolapril is a new angiotensin converting enzyme (ACE) inhibitor that effectively lowers blood pressure in doses up to 2 mg. ...Bl …
Clinical experiences with trandolapril.
Gaillard CA, de Leeuw PW. Gaillard CA, et al. Am Heart J. 1993 May;125(5 Pt 2):1542-6. doi: 10.1016/0002-8703(93)90453-g. Am Heart J. 1993. PMID: 8480627 Review.
In this article the clinical experiences with the new non-sulfhydryl angiotensin-converting enzyme inhibitor trandolapril are reviewed. The drug lowers blood pressure effectively in patients with mild-to-severe hypertension including elderly and obese patients. ...
In this article the clinical experiences with the new non-sulfhydryl angiotensin-converting enzyme inhibitor trandolapril are reviewe …
Fixed combination verapamil SR/trandolapril.
Dooley M, Goa KL. Dooley M, et al. Drugs. 1998 Nov;56(5):837-44; discussion 845-6. doi: 10.2165/00003495-199856050-00010. Drugs. 1998. PMID: 9829157 Review.
The reduction in sitting or supine diastolic and systolic blood pressure is greater after verapamil SR/trandolapril (180/2 to 240/4 mg) than after monotherapy with verapamil SR (180 and 240 mg/day) or trandolapril (2 to 8 mg/day). Fewer cardiac events occurred after …
The reduction in sitting or supine diastolic and systolic blood pressure is greater after verapamil SR/trandolapril (180/2 to 240/4 m …
741 results